Abstract P2-12-24: A phase I/Ib trial of the CDK4/6 antagonist ribociclib and the HDAC inhibitor belinostat in patients with metastatic triple negative breast cancer and recurrent ovarian cancer with response prediction by genomics (CHARGE)
Year: 2025
Type: conference-abstract
Source: Clinical Cancer Research
Authors: Talicia Savage, John G Lamb, Elyse D’Astous, Shashank Sama, Kristen Kelley, Christos Vaklavas, Namita Chittoria, Lauren Mauro, Kathleen Harnden, Takada Harris, Adam L Cohen, Theresa L Werner
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4411284748